Acral lentiginous melanoma. Part I. Epidemiology, etiology, clinical presentation, and diagnosis
Journal of the American Academy of Dermatology · 2026
DOI: 10.1016/j.jaad.2024.10.124 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of the American Academy of Dermatology, 2026. Verfasst von Sach Thakker und 7 weiteren Autor:innen. Beteiligte Einrichtung: Georgetown University School of Medicine, Washington, District of Columbia. Hauptthemen laut MEDLINE: Skin Neoplasms, Melanoma. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 81 Literaturangaben.
Abstract (Originalsprache)
This review article focuses on acral lentiginous melanoma (ALM), a rare cutaneous malignancy and the least common subtype of cutaneous malignant melanoma. ALM exhibits distinct characteristics, such as low overall mutation rates and increased chromosomal alterations. It is associated with worse prognosis, more advanced disease, and lower survival rates compared to other cutaneous malignant melanoma subtypes. The incidence of ALM varies globally, with higher rates in non-White populations, particularly affecting Black, Hispanic, and Asian individuals. Racial disparities may be attributed to a lack of awareness, biological/genetic differences, cultural values, and socioeconomic status. The etiology of ALM remains unknown, but studies suggest a limited impact of UV radiation, potential links to trauma and stress, and a unique tumor immune microenvironment. Diagnostic challenges include varied clinical presentations, with specific biopsy techniques recommended. Clinical research on ALM lacks representation from diverse populations, ultimately limiting its translatability. Understanding the molecular landscape and clinical aspects of ALM will be crucial for improved diagnosis, treatment, and addressing health disparities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Georgetown University School of Medicine, Washington, District of Columbia.
- Department of Dermatology, Johns Hopkins School of Medicine, Baltimore, Maryland; Department of Dermatology, Cleveland Clinic, Cleveland, Ohio.
- Tufts University School of Medicine, Boston, Massachusetts.
- Department of Pathology, Keck School of Medicine, University of Southern California, Los Angeles, California; Department of Dermatology, Keck School of Medicine, University of Southern California, Los Angeles, Californi…
- Department of Dermatology, Keck School of Medicine, University of Southern California, Los Angeles, California; Department of Oncology, Keck School of Medicine, University of Southern California, Norris Comprehensive Ca…
- Department of Dermatology, George Washington University, Washington, District of Columbia. Electronic address: vpatel@mfa.gwu.edu.
Zitieren
APA
Thakker, S., Jaguan, D., Belzberg, M., Gulati, N., Campbell, J. R., DeClerck, B. K., In, G. K., & Patel, V. A. (2026). Acral lentiginous melanoma. Part I. Epidemiology, etiology, clinical presentation, and diagnosis. Journal of the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2024.10.124
Vancouver
Thakker S, Jaguan D, Belzberg M, Gulati N, Campbell JR, DeClerck BK, et al. Acral lentiginous melanoma. Part I. Epidemiology, etiology, clinical presentation, and diagnosis. Journal of the American Academy of Dermatology. 2026. doi:10.1016/j.jaad.2024.10.124
BibTeX
@article{Thakker2026,
author = {Thakker, Sach and Jaguan, Daniella and Belzberg, Micah and Gulati, Nina and Campbell, Janeth R and DeClerck, Brittney K and In, Gino K and Patel, Vishal A},
title = {Acral lentiginous melanoma. Part I. Epidemiology, etiology, clinical presentation, and diagnosis},
journal = {Journal of the American Academy of Dermatology},
year = {2026},
doi = {10.1016/j.jaad.2024.10.124}
}
EUVIMED